PPT-Transfusion:

An EvidenceBased Approach Haneen Yasin Abdella MD Hematology Oncology Kidz Medical Services Miami Childrens Hospital Objectives Review the definite indications for leukoreduced. Lyle R. Petersen, MD, MPH. Brad Biggerstaff, PhD. Division of Vector-Borne Diseases. Centers for Disease Control and Prevention. Blood Products Advisory Committee Meeting. December 14, 2010. Agenda. Arbovirus risk model. “Blood transfusion is like marriage: it should not be entered upon lightly, unadvisedly or wantonly or more often than is absolutely necessary. .” . . –Robert Beal, past director of International Federation of Red Cross. Reduce Complications of . Prematurity. . A . Multi-site Quality Improvement Project. Sponsored . by the Indiana State Department of . Health. . Presenter: Sandra Hoesli, MD, MS. Objectives. Describe the Indiana Vermont Oxford Network Quality Collaborative (. Elizabeth S. Allen, MD. Outline. Platelets. Problems with Platelets. Pathogen Reduced Platelets. UCSD Implementation Strategy. Objectives. Understand the risks of conventional platelet transfusion. Describe the mechanism and effects of pathogen reduction technology. Reduce Complications of . Prematurity. . A . Multi-site Quality Improvement Project. Sponsored . by the Indiana State Department of . Health. . Presenter: Sandra Hoesli, MD, MS. Objectives. Describe the Indiana Vermont Oxford Network Quality Collaborative (. Dr. Soheila . zareifar. Department of pediatric hematology/oncology. Shiraz university of medical sciences. Qeshm. 2018. Transfusion in Sickle Cell. In sickle cell disease transfusions improve blood flow by reducing the proportion of red cells capable of forming sickle hemoglobin polymer. . in children. . Packed cell, platelet, FFP, cryoprecipitate, WBC. Packed red cell. Transfusion. Packed red cells. . Average hematocrit of a unit is 65-75%. ( concentrated). Estimated unit size : 250-350 cc. GI bleed. , . septic shock. , . cardiac surgery. , . TBI. , and in . most ICU patients. . . • Massive transfusion protocols (MTP) (e.g., trauma pts or massive GI bleed) target hemodynamic stability not a specific Hb. Among patients receiving MTP, . Objectives. Describe the physiology of oxygen delivery. List risks and benefits of red blood cell transfusions. Discuss the evidence regarding thresholds for red blood cell transfusion. Explain methods to prevent the need for intra- and post-operative transfusions. . Daradka. University Of Jordan. School Of Medicine. General . S. urgery Department . A Transfusion Dilemma. A 72 year old woman presents to ER with a nosebleed. This is her second visit in 24 hours with the same complaint. Her nose is packed and the bleeding stops.. Dr Bijan Keikhaei. Full Professor of Pediatric . Hematology and Oncology. Research Center for Thalassemia and Hemoglobinopathy, Health Institute, Ahvaz Jundishapur University of Medical Sciences. Introduction. .” . . –Robert Beal, past director of International Federation of Red Cross. Transfusions: History. 1660s: First experiments in blood transfusion, transfused dog blood to humans. Patient died and experiments were banned.. A candidate admitted to undergo a Three year M.D. Transfusion Medicine Released October 2014 Table of ContentsIntroductionDevelopment of a Massive Transfusion Protocol: Engagement and ScopeTriggers for Initiating Massive TransfusionBlood Product Resuscitation in the Trau